Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

ClinicalTrials.gov ID: NCT00916006

Public ClinicalTrials.gov record NCT00916006. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Parallel Group, Double-blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, 0.015% In Patients With Actinic Keratoses ON the Head (Face or Scalp) (REGION-IIa)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.

Study identification

NCT ID
NCT00916006
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Peplin
Industry
Enrollment
269 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2009 (Type not available)
Primary completion
Sep 2009 (Actual)
Completion
Sep 2009 (Actual)
Last update posted
Apr 2, 2015

2009

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Dermatology Research Associates Los Angeles California 90045 —
Dermatology Specialists Inc Oceanside California 92056 —
Skin Surgery Medical Group Inc. San Diego California 92117 —
Conant Medical Group San Francisco California 94114 —
University of Miami, Skin Research Camp Miami Florida 33136 —
Atlanta Dermatology, Vein & Research Center, LLC Alpharetta Georgia 30022 —
Medaphase Inc Newnan Georgia 30263 —
Glazer Dermatology Buffalo Grove Illinois 60089 —
Dawes Fretein Clinical Research Group, LLC Indianapolis Indiana 46256 —
Pedia Research LLC Owensboro Kentucky 42301 —
Hamzavi Dermatology Fort Gratiot Michigan 48059 —
Minnesota Clinical Study Center Fridley Minnesota 55432 —
Wake Research Associates Raleigh North Carolina 27612 —
Dermatology Research Associates Nashville Tennessee 37203 —
J & S Studies, Inc. College Station Texas 77845 —
Dermatology Associates of Tyler Tyler Texas 75703 —
Center for Clinical Studies Webster Texas 77598 —
Dermatology Research Center, Inc. Salt Lake City Utah 84124 —
Virginia Clinical Research, Inc Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00916006, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00916006 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →